Integrin inhibitor, RGD (Arg-Gly-Asp) peptide, Purity ≥98%

Synonym: 99896-85-2; Arginyl-glycyl-aspartic acid; Rgd peptide; (2S)-2-[[2-[[(2S)-2-Amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]butanedioic acid

MDL: MFCD00057952
CAS Number: 99896-85-2
Compound CID: 104802

Product Size

10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

RGD (Arg-Gly-Asp) peptide, soluble in DMSO and water and insoluble in ethanol, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.

Molecular Weight

346.34

Molecular Formula

C₁₂H₂₂N₆O₆

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Solubility

In vitro: DMSO: insoluble; Water: 11 mg/mL (31.75 mM); Ethanol: insoluble

Stability

In its lyophilized form, the chemical remains stable for 36 months.

Quality Level

Research grade

Applications

RGD (Arg-Gly-Asp) peptide is a cytoskeletal signaling inhibitor that can be used for its potential to target integrins in cancer therapy and tissue engineering.

Storage

Store at -20ºC, and keep desiccated.